Q4 2025 CVS Health Corp Earnings Call Transcript
Key Points
- CVS Health Corp (CVS) reported strong financial performance for the fourth quarter of 2025, with adjusted operating income of $2.6 billion and adjusted earnings per share of $1.09.
- The company exceeded its initial expectations for full-year 2025, delivering adjusted earnings per share of $6.75 and operating cash flow of $10.6 billion.
- CVS Health Corp (CVS) made significant progress in its Aetna business, improving financial results with a year-over-year adjusted operating income increase of over $2.6 billion.
- The company successfully completed the transition to a cost-based reimbursement model, creating a more transparent and stable pharmacy market.
- CVS Health Corp (CVS) continues to focus on improving connectivity between its businesses, using technology to support greater interoperability and facilitate a common experience for consumers.
- The proposed 2027 Medicare Advantage advance rate notice does not match the level of medical cost trend in the industry, posing a challenge for CVS Health Corp (CVS).
- The company experienced a modest decline in adjusted operating income in its Health Care Benefits segment due to changes in the seasonality of the Medicare Part D program.
- CVS Health Corp (CVS) faced a deterioration of its risk adjustment position in its individual exchange business and increased flu activity late in the quarter.
- The company continues to face pharmacy reimbursement pressure and the impact of recent generic drug introductions.
- Medical cost trends remain elevated across all products, impacting the company's financial outlook for 2026.
Hello and welcome to CVS Health's fourth quarter 2025 earnings call. (Operator Instructions) I would now like to pass the call to Larry McGrath, Chief Strategy Officer. Larry, please proceed.
Good morning, and welcome to the CVS Health fourth quarter 2025 earnings call and webcast. I'm Larry McGrath, Executive Vice President of Capital Markets at CVS Health.
I'm joined this morning by David Joyner, Chair and Chief Executive Officer; and Brian Newman, Chief Financial Officer. Following our prepared remarks, we'll host a question-and-answer session will include additional members of the leadership team.
Our press release and slide presentation have been posted to our website, along with our Form 10-K filed this morning with the SEC. Today's call is also being broadcast on our website. During this call, we'll make certain forward-looking statements.
Our forward-looking statements are subject to significant risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
